Larry James Anderson MD
Professor, Pediatrics, Emory University School of Medicine
Join to View Full Profile
2076 Continental Dr NeAtlanta, GA 30345
Phone+1 404-712-6604
Dr. Anderson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1980 - 1981
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1974 - 1977
Harvard Medical SchoolClass of 1974
Certifications & Licensure
GA State Medical License 1977 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19 Start of enrollment: 2021 Apr 14
Publications & Presentations
PubMed
- A Phase 1 randomized trial of homologous and heterologous filovirus vaccines with a late booster dose.Christina A Rostad, Inci Yildirim, Carol Kao, Jumi Yi, Satoshi Kamidani
NPJ Vaccines. 2024-12-23 - 2 citationsRelative Contribution of Diagnostic Testing to the Diagnosis of Respiratory Syncytial Virus in Hospitalized Adults in the United States.Evan J Anderson, Ashley Tippett, Elizabeth Begier, Theda Gibson, Gabby Ess
The Journal of Infectious Diseases. 2024-12-16 - 1 citationsContribution of Gestational Weight Gain to Childhood Asthma Phenotypes: A Prospective Cohort Study.Akihiro Shiroshita, Tebeb Gebretsadik, Larry J Anderson, William D Dupont, Sarah Osmundson
The Journal of Allergy and Clinical Immunology. in Practice. 2024-10-01
Journal Articles
- MUC5AC Levels Associated with Respiratory Syncytial Virus Disease SeverityLarry Anderson, MD, Clinical Infectious Diseases
Press Mentions
KHN Morning BriefingJanuary 18th, 2023- Treatment Reduces Symptoms, Viral Load in Respiratory Syncytial Virus Challenge StudyFebruary 18th, 2022
The Marcus Foundation Renews Support for 15 Physician ResearchersOctober 19th, 2018
Grant Support
- F plus G RSV VLP Vaccine for Improved Safety and EfficacyRAZI PHARMA LLC2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
